Precigen, Inc.
PGEN
$4.07
-$0.115-2.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.13% | -23.40% | -37.39% | -41.55% | -80.17% |
| Total Other Revenue | 176.00% | 182.35% | 266.67% | 8.70% | -72.53% |
| Total Revenue | -1.12% | -22.76% | -36.95% | -41.38% | -80.14% |
| Cost of Revenue | 6.21% | -11.90% | -26.04% | 32.17% | 1.88% |
| Gross Profit | -6.85% | 10.93% | 25.11% | -46.76% | -59.61% |
| SG&A Expenses | 23.57% | 11.75% | 2.17% | -2.65% | -6.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.63% | 1.89% | 3.66% | 5.56% | 3.44% |
| Operating Income | 0.61% | -3.38% | -6.50% | -9.19% | -28.41% |
| Income Before Tax | 9.36% | -62.74% | -32.86% | -66.31% | -88.18% |
| Income Tax Expenses | 96.50% | -308.33% | -291.48% | -1,627.12% | -1,169.14% |
| Earnings from Continuing Operations | 8.04% | -61.65% | -31.63% | -64.15% | -85.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.04% | -61.65% | -31.63% | -64.15% | -711.20% |
| EBIT | 0.61% | -3.38% | -6.50% | -9.19% | -28.41% |
| EBITDA | -3.70% | -7.23% | -9.63% | -16.75% | -39.52% |
| EPS Basic | 20.77% | -46.69% | -22.65% | -47.68% | -475.23% |
| Normalized Basic EPS | -15.29% | -29.58% | -2.87% | 0.21% | -9.93% |
| EPS Diluted | 20.77% | -46.69% | -22.65% | -47.68% | -475.23% |
| Normalized Diluted EPS | -15.29% | -29.58% | -2.87% | 0.21% | -9.93% |
| Average Basic Shares Outstanding | 16.05% | 12.13% | 9.78% | 10.73% | 13.64% |
| Average Diluted Shares Outstanding | 16.05% | 12.13% | 9.78% | 10.73% | 13.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |